• Sonnet BioTherapeutics agrees to buy Relief Therapeutics pharmaceutical-technology
    August 14, 2019
    Biotechnology company Sonnet BioTherapeutics has agreed to acquire all outstanding shares of Relief Therapeutics under a binding share exchange agreement with Relief Therapeutics Holding.
PharmaSources Customer Service